125 related articles for article (PubMed ID: 25702759)
1. Overview of the study protocols and statistical analysis plan for the Saline versus Plasma-Lyte 148 for Intravenous Fluid Therapy (SPLIT) research program.
Reddy SK; Young PJ; Beasley RW; Mackle DM; McGuinness SP; McArthur CJ; Henderson SJ; Weinberg L; French CJ; Orford NR; Bailey MJ; Bellomo R
Crit Care Resusc; 2015 Mar; 17(1):29-36. PubMed ID: 25702759
[TBL] [Abstract][Full Text] [Related]
2. A protocol for the 0.9% saline versus Plasma-Lyte 148 for intensive care fluid therapy (SPLIT) study.
Reddy SK; Bailey MJ; Beasley RW; Bellomo R; Henderson SJ; Mackle DM; McArthur CJ; Mehrtens JE; Myburgh JA; McGuinness SP; Psirides AJ; Young PJ
Crit Care Resusc; 2014 Dec; 16(4):274-9. PubMed ID: 25437221
[TBL] [Abstract][Full Text] [Related]
3. The effects of 0.9% saline versus Plasma-Lyte 148 on renal function as assessed by creatinine concentration in patients undergoing major surgery: A single-centre double-blinded cluster crossover trial.
Weinberg L; Li MH; Churilov L; Macgregor C; Garrett K; Eyles J; Bellomo R
PLoS One; 2021; 16(5):e0251718. PubMed ID: 34010324
[TBL] [Abstract][Full Text] [Related]
4. Effect of 0.9% Saline or Plasma-Lyte 148 as Crystalloid Fluid Therapy in the Intensive Care Unit on Blood Product Use and Postoperative Bleeding After Cardiac Surgery.
Reddy SK; Bailey MJ; Beasley RW; Bellomo R; Mackle DM; Psirides AJ; Young PJ
J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1630-1638. PubMed ID: 28774642
[TBL] [Abstract][Full Text] [Related]
5. Saline versus balanced crystalloids for intravenous fluid therapy in the emergency department: study protocol for a cluster-randomized, multiple-crossover trial.
Self WH; Semler MW; Wanderer JP; Ehrenfeld JM; Byrne DW; Wang L; Atchison L; Felbinger M; Jones ID; Russ S; Shaw AD; Bernard GR; Rice TW
Trials; 2017 Apr; 18(1):178. PubMed ID: 28407811
[TBL] [Abstract][Full Text] [Related]
6. Study protocol for the Balanced Solution versus Saline in Intensive Care Study (BaSICS): a factorial randomised trial.
Zampieri FG; Azevedo LCP; Corrêa TD; Falavigna M; Machado FR; Assunção MSC; Lobo SMA; Dourado LK; Berwanger O; Kellum JA; Brandão N; Cavalcanti AB;
Crit Care Resusc; 2017 Jun; 19(2):175-182. PubMed ID: 28651514
[TBL] [Abstract][Full Text] [Related]
7. Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.
Collins MG; Fahim MA; Pascoe EM; Dansie KB; Hawley CM; Clayton PA; Howard K; Johnson DW; McArthur CJ; McConnochie RC; Mount PF; Reidlinger D; Robison L; Varghese J; Vergara LA; Weinberg L; Chadban SJ;
Trials; 2020 May; 21(1):428. PubMed ID: 32450917
[TBL] [Abstract][Full Text] [Related]
8. Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial.
Young P; Bailey M; Beasley R; Henderson S; Mackle D; McArthur C; McGuinness S; Mehrtens J; Myburgh J; Psirides A; Reddy S; Bellomo R; ;
JAMA; 2015 Oct; 314(16):1701-10. PubMed ID: 26444692
[TBL] [Abstract][Full Text] [Related]
9. The Plasma-Lyte 148 v Saline (PLUS) study protocol: a multicentre, randomised controlled trial of the effect of intensive care fluid therapy on mortality.
Hammond NE; Bellomo R; Gallagher M; Gattas D; Glass P; Mackle D; Micallef S; Myburgh J; Saxena M; Taylor C; Young P; Finfer S
Crit Care Resusc; 2017 Sep; 19(3):239-246. PubMed ID: 28866974
[TBL] [Abstract][Full Text] [Related]
10. Balanced crystalloids versus saline in the intensive care unit: study protocol for a cluster-randomized, multiple-crossover trial.
Semler MW; Self WH; Wang L; Byrne DW; Wanderer JP; Ehrenfeld JM; Stollings JL; Kumar AB; Hernandez A; Guillamondegui OD; May AK; Siew ED; Shaw AD; Bernard GR; Rice TW; ;
Trials; 2017 Mar; 18(1):129. PubMed ID: 28302179
[TBL] [Abstract][Full Text] [Related]
11. Effect of saline 0.9% or Plasma-Lyte 148 therapy on feeding intolerance in patients receiving nasogastric enteral nutrition.
Reddy S; Bailey M; Beasley R; Bellomo R; Mackle D; Psirides A; Young P
Crit Care Resusc; 2016 Sep; 18(3):198-204. PubMed ID: 27604334
[TBL] [Abstract][Full Text] [Related]
12. 0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial.
Williams V; Jayashree M; Nallasamy K; Dayal D; Rawat A
Crit Care; 2020 Jan; 24(1):1. PubMed ID: 31898531
[TBL] [Abstract][Full Text] [Related]
13. A multicentre randomised controlled pilot study of fluid resuscitation with saline or Plasma-Lyte 148 in critically ill patients.
Verma B; Luethi N; Cioccari L; Lloyd-Donald P; Crisman M; Eastwood G; Orford N; French C; Bellomo R; Martensson J
Crit Care Resusc; 2016 Sep; 18(3):205-12. PubMed ID: 27604335
[TBL] [Abstract][Full Text] [Related]
14. Physico-chemical stability of Plasma-Lyte 148® and Plasma-Lyte 148® + 5% Glucose with eight common intravenous medications.
Dawson R; Wignell A; Cooling P; Barrett D; Vyas H; Davies P
Paediatr Anaesth; 2019 Feb; 29(2):186-192. PubMed ID: 30472805
[TBL] [Abstract][Full Text] [Related]
15. Is the infusion of Plasma-Lyte 148 and 5% Glucose into peripheral veins really problematic?
Fihlman M; Kataja JT
Acta Paediatr; 2018 Nov; 107(11):2026-2027. PubMed ID: 29953656
[No Abstract] [Full Text] [Related]
16. 0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to PICU-a randomized controlled trial (SPLYT-P): study protocol for an intravenous fluid therapy trial.
Raman S; Schibler A; Marsney RL; Trnka P; Kennedy M; Mattke A; Gibbons K; Schlapbach LJ
Trials; 2021 Jul; 22(1):427. PubMed ID: 34217337
[TBL] [Abstract][Full Text] [Related]
17. Sodium reduction during cardiopulmonary bypass: Plasma-Lyte 148 versus trial fluid as pump primes.
Morgan TJ; Presneill JJ; Davies PG; Power G; Venkatesh B
Crit Care Resusc; 2015 Dec; 17(4):263-7. PubMed ID: 26640062
[TBL] [Abstract][Full Text] [Related]
18. Effect of 0.9% NaCl compared to plasma-lyte on biomarkers of kidney injury, sodium excretion and tubular transport proteins in patients undergoing primary uncemented hip replacement - a randomized trial.
Østergaard AM; Jørgensen AN; Bøvling S; Ekeløf NP; Mose FH; Bech JN
BMC Nephrol; 2021 Mar; 22(1):111. PubMed ID: 33771116
[TBL] [Abstract][Full Text] [Related]
19. Multicentre randomised controlled trial: protocol for Plasma-Lyte Usage and Assessment of Kidney Transplant Outcomes in Children (PLUTO).
Hayes W; Laing E; Foley C; Pankhurst L; Thomas H; Hume-Smith H; Marks S; Kessaris N; Bryant WA; Spiridou A; Wray J; Peters MJ
BMJ Open; 2022 Mar; 12(3):e055595. PubMed ID: 35288387
[TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte® 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers.
Chowdhury AH; Cox EF; Francis ST; Lobo DN
Ann Surg; 2012 Jul; 256(1):18-24. PubMed ID: 22580944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
